Rates of Alzheimer's Disease rising, how Congress is addressing the need for care
(WTAJ) — Rates of Alzheimer's Disease is on the rise at a time when the nation is facing a shortage of caregivers.
According to the Alzheimer's Association, there are now an estimated seven million people diagnosed with Alzheimer's who are, in most cases, being cared for by family. Julie Steinbacher, an elder and estate planning lawyer who volunteers her time as an advocate with the Alzheimer's Association Greater Pennsylvania Chapter, said taking care of a loved one with dementia can be a full time job for caretakers.
Cambria County Clothing Boutique helps children get free clothing
'60% of them are still working. But of those people that're still working, 57% of them are going to end up having to do something with their job, take a leave of absence, go in late, leave early, Steinbacher said.
Steinbacher was a caretaker for her own mother. She said that along with the emotional burden of being a caregiver also comes financial burden. Some caregivers find themselves on the line for the cost of adult day care, home care aides, home modifications or prescription copays.
Lawmakers are proposing the Credit for Caring Act which would provide a tax credit of up-to $5,000 or 30% of costs for those caring for someone with a diagnosed chronic illness if their expenses cost more than $2,000 annually.
Steinbacher said this legislation could even help reduce rates of elder abuse.
'Elder abuse is rampant, but it happens for many different reasons. Some of the reasons that it happens for is just totally wrong and, unthinkable. But sometimes it's situations where people really are trying to do a good job and they don't have the resources to do it,' Steinbacher said.
The bill was introduced in January 2024 and is still being reviewed.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
2 hours ago
- Boston Globe
RFK Jr. wants to allow more experimental therapies, acknowledging health risks and threat of ‘charlatans'
'And of course you're going to get a lot of charlatans, and you're going to get people who have bad results,' he added. 'And ultimately, you can't prevent that either way. Leaving the whole thing in the hands of pharma is not working for us.' Advertisement Kennedy cited his own experience at a clinic in Antigua, where he said he received a stem cell treatment that 'enormously' eased his neurological condition, spasmodic dysphonia, which affects his voice and has few treatment options. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up If Kennedy does permit broader use of unauthorized or experimental therapies, he would be reversing long-standing efforts by the FDA to monitor and sometimes police the emerging field. Experts, including some who support alternative medicine, worry that without safeguards, an expansion of such treatments could undermine legitimate development of new therapies. The FDA now narrowly permits stem cell therapies to treat blood and immune disorders. Nearly a decade ago, the field was so loosely regulated that the agency pursued court actions to shut down rogue clinics using unauthorized treatments for a wide array of ailments. Some providers in the United States and in other countries continue to offer experimental stem cell therapies for everything from autism to Alzheimer's to erectile dysfunction. Advertisement The latest move reflects an expansion of Kennedy's drive to dismantle federal health policy to reflect his long-held views, which had so far focused mainly on vaccines, chronic diseases, food dyes and fluoride. A push to open up the field of unregulated stem cell infusions meshes with his oft-stated contention that the FDA is a 'sock puppet' for major drug companies and faces a crisis of distrust. Wellness industry products, he has claimed, are unfairly sidelined. A spokesperson for the Department of Health and Human Services did not respond to requests for comment. Kennedy's statements alarmed experts on the field of sometimes dangerous stem cell infusions -- who noted that many of Kennedy's allies endorse wellness products ranging from red-light therapy to magnetism. 'It's a complete abdication of protection of the public, letting these grifters go forward,' said Timothy Caulfield, a research chair in health law and policy at the University of Alberta in Canada. 'For him to say, 'There are problems with Big Pharma, so we want our opportunity to be bad actors too,' it doesn't make any sense.' One leading expert group, the International Society for Stem Cell Research, reviewed Kennedy's podcast statements and condemned the approach as potentially allowing products that are 'sometimes contaminated with pathogens and are often marketed with scientifically implausible claims.' 'It is critical that the FDA maintain its regulatory authority to protect Americans from these potentially harmful and deceptive products,' the society said in a statement. Advertisement On Thursday, a panelist appearing at an FDA meeting on cell and gene therapies raised a concern about 'snake oil' treatments. Dr. Vinay Prasad, the agency's director of the center for biologics evaluation research, responded, 'We have to regulate the bad actors. We can't let that taint what we do here at the FDA.' Kennedy, who also attended the event, voiced full support for the researchers and biotech executives working on gene therapies for rare diseases, including those who made history by creating a custom gene therapy for an infant named KJ. 'We're going to do everything in our power to sweep away the barriers from you getting those solutions to market and getting them funded, and do everything that we can to support you all,' Kennedy said. On Brecka's podcast in May, Kennedy cited other products that he'd like to see more of, including chelation treatment, which was discussed in a 2015 book edited by him that focused on widely debunked theories about mercury in vaccines and autism and cites 'evidence of chelation's benefits' from a few small studies. One 5-year-old Pennsylvania boy died in 2005 from cardiac arrest after a doctor tried to treat his autism with chelation. Neither Kennedy nor the FDA has released a formal plan to change agency standards for stem cell treatments, which have typically been reviewed by the agency as individual therapies to treat a specific disease. Widening overall access could also happen informally if the agency decided to relax enforcement, an approach the FDA used in the past to indicate that it wouldn't crack down on unauthorized products. During the pandemic, for example, the agency allowed providers to retrofit infusion pumps and ventilators to treat hordes of sick patients. Advertisement During the first Trump administration, the agency's commissioner, Dr. Scott Gottlieb, escalated enforcement against stem cell providers whom he described in 2017 as 'unscrupulous actors who have seized on the clinical promise of regenerative medicine.' The FDA followed through with lawsuits seeking to stop some stem cell providers, including one case that the government won on appeal in the fall. In that case, the agency alleged that one provider, the California Stem Cell Treatment Center, was offering a drug without FDA approval by taking stem cells from a person's fat, manipulating them and infusing them as a remedy for Alzheimer's disease, cancer and arthritis. The agency classifies stem cell treatments as a 'biologic' and approves them much like a drug after careful studies of safety and effectiveness. But the FDA does make exceptions: It does not regulate some treatments if providers say they are extracting and then reinserting a person's cells with minimal manipulation. In March, Kennedy convened a meeting with leaders in the stem cell field. Two people who attended said the gathering was a fact-finding effort to explore a safe way to increase access. To Dr. Noah Raizman, who attended the meeting on behalf of the American Academy of Orthopaedic Surgeons, Kennedy's new pronouncement 'sounds a little more casual and a little bit more emboldened.' In the podcast, Kennedy said that consumers should be able to navigate the industry's claims. 'We don't want to have the Wild West,' Kennedy said. 'We want to make sure that information is out there. But we also want to respect the intelligence of the American people -- the capacity of people who explore the outcomes that are going to benefit them the most.' Advertisement In recent years, stem cell treatments have caused harm in the United States and abroad. Experts at the Pew Research Center tallied more than 350 cases of side effects including life-threatening blood infections, heart attacks and tumors. One Boston neurosurgeon discovered a huge mass of bloody tissue in the lower spine of a man who had received unproven stem cell treatments in Mexico, China and Argentina. Three patients were blinded after stem cell treatments at a Florida clinic. The FDA prevailed in getting a court order to stop the clinic from operating. The field of stem cell treatments is so complex that the Harvard Medical School created a free course to help doctors navigate patient questions, said Insoo Hyun, the director of life sciences at the Museum of Science in Boston. More than 110 stem cell clinical studies are advancing under regulatory oversight. In one, scientists at the National Institutes of Health are using retinal cells developed from patients' blood to try to treat vision loss in older adults -- and follow them for 15 years. In another study aimed at helping patients with Parkinson's disease, researchers at a biotech company in California are exploring the safety of infusing dopamine-producing neurons in a region of the brain that controls the body's movements. A Chinese company is studying a treatment for heart failure that involves transplanting cardiac muscle cells into the heart. Some providers sidestep the costly, yearslong process of careful work that can lead to an FDA approval. Among them is Dr. Chadwick Prodromos, a Chicago doctor who offers stem cell treatments in Antigua. Kennedy welcomed him warmly at the March meeting, Raizman recalled. Reached for comment, Prodromos' office said that he was in Antigua doing treatments and was not available. Advertisement In an April interview on YouTube, Prodromos said that he was still in touch with the FDA about stem cell treatments that could help people 'without allowing scams and things that aren't valid. And you know, it's a tricky proposition.' A website for Prodromos' clinic says that he and colleagues offer injections in Antigua into the joints, back, neck, scalp, penis and pelvic floor for an array of conditions including autism, thinning hair and lupus. He uses AlloRX cells, which are derived from the umbilical cord, in a manner that in the United States would require an FDA-cleared clinical trial. People can seek out unregulated treatments using their own cells that are processed, purified and amplified in different ways. They can also find treatments using others' cells that vary widely in quality and sterility. Some low-quality clinics process cells in a back room, which is the opposite of a clinical-grade cell processing site. Hyun said he recently toured one in the Netherlands that used specialized air filtering, layers of gowns and a ban on bacteria-laden cellphones in their sterile area. 'It's kind of like you're entering a space station,' he said. Ultimately, Caulfield said, many unauthorized stem cell providers adopt the language of biotech and regenerative medicine, post glowing patient testimonials and exploit patients who are desperate for a cure. This article originally appeared in .
New York Post
4 hours ago
- New York Post
It's official: Your diet is making you depressed, according to science
Skipping dessert really can leave you down in the dumps. No one who's been on a diet has ever said, 'I love calorie restriction,' but a new study has found a not-so-surprising link between low-cal eating and depression. And some people have it worse than others. 3 Researchers found that men and those whose BMI classified them as overweight were particularly susceptible to diet-linked depression. Studio Romantic – The dietary habits and depressive symptoms of 28,000 US adults were analyzed for the study, published in BMJ Nutrition Prevention & Health. Of these adults, 29% had a healthy weight, 33% were deemed overweight, and 38% were considered obese. The dietary patterns were divided into four categories: calorie-restrictive, nutrient-restrictive (AKA low in fat), sugar, salt, or carbs, established dietary pattern, or not on a diet at all. The majority of participants, 87%, did not follow any specific diet, 8% followed a calorie-restrictive diet, 3% opted for nutrient restriction, and 2% followed an established dietary pattern. Using questionnaires from the US National Health and Nutrition Examination Survey, researchers found that 8% of participants reported depressive symptoms. Those on calorie or nutrient-restrictive diets exhibited higher scores of emotional and physical distress than their cohorts who were not on a specific diet, suggesting that unsupervised restrictive diets may negatively affect mental health. Researchers found that men and those whose BMI classified them as overweight were particularly susceptible to diet-linked depression. 3 Besides affecting your quality of life and relationships, depression can raise the risk of heart disease, diabetes, stroke, dementia, Alzheimer's disease, anxiety disorders, and substance abuse. bravissimos – 'The findings suggest caution with overly restrictive or unbalanced diets, particularly for people already experiencing weight-related stress or challenges,' said lead study author Dr. Venkat Bhat, psychiatrist, clinician-researcher, and director of the Interventional Psychiatry Program at St. Michael's Hospital and University of Toronto. Researchers found that the quality of diet had a direct bearing on depression risk. Those whose diet was rife with ultra-processed foods (UPFs) were more likely to report higher levels of depression. Recent research revealed that 60% of Americans' daily caloric intake comes from ultra-processed foods. UPFs often contain high levels of sodium, refined sugars, cholesterol-spiking fats and other lab-based ingredients. A 2023 study from the Harvard T.H. Chan School of Public Health found that people who consume nine or more servings of UPFs a day have a 50% higher risk of developing depression than those who eat four or fewer daily servings. 3 Previous studies have established that a Mediterranean diet rich in fruit, veggies, nuts, fish, and plants can slash depression risk by a third. Eightshot Images – In contrast, this latest study revealed that those who followed a Mediterranean diet exhibited lower rates of depression. Previous studies have established that a Mediterranean diet rich in fruit, veggies, nuts, fish, and plants can slash depression risk by a third. In a 2023 Gallup poll, 29% of US adults reported having been diagnosed with depression at some point in their lifetime, while 17.8% of Americans said they have depression or are being treated for it. Besides affecting your quality of life and relationships, depression can raise the risk of heart disease, diabetes, stroke, dementia, Alzheimer's disease, anxiety disorders and substance abuse. Given the results of this study, Bhat suggests dieters abstain from strict caloric restriction and instead opt for,' balanced, sustainable dietary changes that meet nutritional needs.' Researchers note that their findings only reveal associations, not definitive data. Further, due to the survey format, there's no way to verify that participants truly adhere to caloric restriction. Still, Bhat and his team are hopeful that future studies will continue to examine the relationship between calorie restriction and mental health.
Yahoo
7 hours ago
- Yahoo
Rosemary has been linked to better memory, lower anxiety and even protection from Alzheimer's
Rosemary (Rosmarinus officinalis), the aromatic herb native to the Mediterranean, has long been treasured in kitchens around the world. But beyond its culinary charm, rosemary is also gaining recognition for its impressive health benefits, especially when it comes to brain health, inflammation and immune function. Research suggests rosemary may even hold promise in the fight against Alzheimer's disease, the leading cause of dementia worldwide. Historically, rosemary has been linked to memory and mental clarity. In ancient Greece and Rome, students and scholars used rosemary in the hope of sharpening concentration and recall. Modern science is finding there may have been something in this: in one study, people who inhaled rosemary's scent performed better on memory tasks compared to those in an unscented environment. So how does rosemary work on the brain? There are several mechanisms at play. For starters, rosemary stimulates blood circulation, including to the brain, helping deliver more oxygen and nutrients, which may improve mental clarity. It also has calming properties; some studies suggest its aroma can reduce anxiety and improve sleep. Lower stress can mean better focus and memory retention. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. Rosemary contains compounds that interact with the brain's neurotransmitters. One such compound, 1,8-cineole, helps prevent the breakdown of acetylcholine, a brain chemical essential for learning and memory. By preserving acetylcholine, rosemary may help support cognitive performance, especially as we age. Another bonus? Rosemary is packed with antioxidants, which help protect brain cells from damage caused by oxidative stress – a major factor in cognitive decline. Rosemary is rich in phytochemicals, plant compounds with health-enhancing effects. One of the most powerful is carnosic acid, an antioxidant and anti-inflammatory agent that helps shield brain cells from harm, particularly from the kinds of damage linked to Alzheimer's disease. Read more: In 2025, researchers developed a stable version of carnosic acid called diAcCA. In promising pre-clinical studies, this compound improved memory, boosted the number of synapses (the connections between brain cells), and reduced harmful Alzheimer's related proteins like amyloid-beta and tau. What's especially exciting is that diAcCA only activates in inflamed brain regions, which could minimise side effects. So far, studies in mice show no signs of toxicity and significant cognitive improvements – raising hopes that human trials could be next. Researchers also believe diAcCA could help treat other inflammatory conditions, such as type 2 diabetes, cardiovascular disease and Parkinson's disease. Rosemary's benefits could extend well beyond the brain. It's been used traditionally to ease digestion, relieve bloating and reduce inflammation. Compounds like rosmarinic acid and ursolic acid are known for their anti-inflammatory effects throughout the body. Rosemary may even benefit the skin – a review suggests it can help soothe acne and eczema, while carnosic acid may offer anti-ageing benefits by protecting skin from sun damage. Rosemary oil also has antimicrobial properties, showing promise in food preservation and potential pharmaceutical applications by inhibiting the growth of bacteria and fungi. For most people, rosemary is safe when used in food, teas or aromatherapy. But concentrated doses or extracts can pose risks. Consuming large amounts may cause vomiting or, in rare cases, seizures – particularly in people with epilepsy. There's also a theoretical risk of rosemary stimulating uterine contractions, so pregnant people should avoid high doses. Because rosemary can interact with some medications – such as blood thinners – it's best to check with a healthcare provider before taking large amounts in supplement form. Rosemary is more than just a kitchen staple. It's a natural remedy with ancient roots and modern scientific backing. As research continues, particularly into breakthrough compounds like diAcCA, rosemary could play an exciting role in future treatments for Alzheimer's and other chronic conditions. In the meantime, adding a little rosemary to your life – whether in a meal, a cup of tea, or a breath of its fragrant oil – could be a small step with big health benefits. This article is republished from The Conversation under a Creative Commons license. Read the original article. Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
